Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia
Aline do Nascimento, Daniel da Silva Pereira Curado, Thaís Montezuma, Wallace Breno Barbosa et autres